Morgan Stanley lowers Amgen (NASDAQ:AMGN) price target from $300 to $291

By / / Amgen

Morgan Stanley analyst Terence Flynn maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and lowers the price target from $300 to $291.

Scroll to Top